Latest news
September 21, 2023
Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers
September 22, 2022
Big Impact, Small Package: Debiopharm Launches a Wazoku Open-Innovation Challenge for Small Antibody Drug Conjugate Technology
February 25, 2021
Debiopharm and Genome & Company Join Forces to Create New Highly Specific Therapies For Cancer Patients